Reference
Fan BE, et al. Reversal of anticoagulation in patients on rivaroxaban or apixaban (DOAC) with major bleeding episodes (MBE) with 4 factor prothrombin complex concentrates (PCC): A multicentre retrospective study. Research and Practice in Thrombosis and Haemostasis 3 (Suppl. 1): 460-461 (plus poster) abstr. PB1476, 2019. Available from: URL: http://doi.org/10.1002/rth2.12229 [abstract] - Singapore
Rights and permissions
About this article
Cite this article
Prothrombin-complex-concentrate. Reactions Weekly 1767, 267 (2019). https://doi.org/10.1007/s40278-019-66638-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-66638-9